Risks for HPV-associated diseases: other than HPV, do they exist?

ISSN： 1743-2871

Source： Papillomavirus Report, Vol.16, Iss.6, 2005-11, pp. : 393-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The imidazoquinolines — mechanism of action and therapeutic potential in HPV-associated disease

By Stanley Margaret A.

Papillomavirus Report, Vol. 16, Iss. 3, 2005-05 ,pp. : 141-146

Maney Publishing

Access to resources Recommend Favorite

Methylation status of HPV16 E2‐binding sites classifies subtypes of HPV‐associated oropharyngeal cancers

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1966-1976

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term prognosis and risk factors among patients with HPV‐associated oropharyngeal squamous cell carcinoma

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3462-3471

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Significance of Inactivated Glycogen Synthase Kinase 3β in HPV‐Associated Cervical Cancer: Relationship with Wnt/β‐Catenin Pathway Activation

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ELECTRONIC), Vol. 73, Iss. 5, 2015-05 ,pp. : 460-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Men's perspectives on cancer prevention behaviors associated with HPV

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 27, Iss. 2, 2018-02 ,pp. : 484-491

John Wiley & Sons Inc

Access to resources Recommend Favorite